AstraZeneca, Bristol Myers, McKesson Snag Early Win In MDL
A Kentucky federal judge on Tuesday handed AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb Co. and McKesson Corp. an early win in multidistrict litigation over their diabetes drugs Onglyza and Kombiglyze, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article